Responses
Therapeutics
Randomised controlled trial
Valsartan is more effective than placebo in reducing the incidence of diabetes in people with impaired glucose tolerance and cardiovascular disease or risk factors but has no effect on cardiovascular outcomes
Compose a Response to This Article
Other responses
No responses have been published for this article.